Vascular Biogenics (NASDAQ:VBLT) Receives New Coverage from

StockNews.com started coverage on shares of Vascular Biogenics (NASDAQ:VBLT – Free Report) in a research note released on Tuesday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Vascular Biogenics Stock Down 7.5 % NASDAQ VBLT opened at $0.26 on Tuesday. The company has a market capitalization of $17.91 million, a price-to-earnings […]

Related Keywords

United States , Israel , , Advisor Group Holdings Inc , Medicard Ltd , Vascular Biogenics Company Profile , Renaissance Technologies , Envestnet Asset Management Inc , Vascular Biogenics Ltd , Vascular Biogenics , Free Report , Biogenics Stock Down , Get Free Report , Asset Management , Sigma Investments , Advisor Group Holdings , Group Holdings , Biogenics Ltd , Vascular Biogenics Daily , Nasdaq Vblt , Vblt , Medical , Initiated Coverage , Stocknews Com ,